for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

MEDNAX Inc

MD.N

Latest Trade

24.21USD

Change

-0.21(-0.86%)

Volume

80,791

Today's Range

23.88

 - 

24.47

52 Week Range

20.28

 - 

35.67

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
24.42
Open
24.07
Volume
80,791
3M AVG Volume
8.91
Today's High
24.47
Today's Low
23.88
52 Week High
35.67
52 Week Low
20.28
Shares Out (MIL)
86.45
Market Cap (MIL)
2,162.18
Forward P/E
16.20
Dividend (Yield %)
--

Next Event

Q4 2021 MEDNAX Inc Earnings Release

Latest Developments

More

Mednax Q3 Adjusted Non-GAAP EPS $0.46 From Continuing Operations

Mednax Posts Q2 Adjusted Non-Gaap Earnings Per Share $0.41 From Continuing Operations

Hera Med Signs Agreement With Obstetrix Medical Group

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About MEDNAX Inc

Mednax, Inc. is a provider of physician services including newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The Company's national network comprises of affiliated physicians who provide clinical care in approximately 39 states and Puerto Rico. Its affiliated physicians provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications; and maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. Its network also includes other pediatric subspecialists, including those who provides pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care, pediatric ear, nose and throat, pediatric ophthalmology, pediatric urology services and pediatric urgent care.

Industry

Healthcare Facilities

Contact Info

1301 Concord Ter

SUNRISE, FL

33323-2843

United States

+1.954.3840175

https://www.mednax.com/

Executive Leadership

Guy P. Sansone

Independent Chairman of the Board

Mark S. Ordan

Chief Executive Officer, Director

C. Marc Richards

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

Roger Hinson

President, Pediatrix and Obstetrix Medical Group

Dominic J. Andreano

Executive Vice President, General Counsel, Secretary

Key Stats

3.00 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

3.6K

2019

3.5K

2020

1.7K

2021(E)

1.9K
EPS (USD)

2018

3.820

2019

3.380

2020

0.950

2021(E)

1.552
Price To Earnings (TTM)
29.73
Price To Sales (TTM)
1.18
Price To Book (MRQ)
2.56
Price To Cash Flow (TTM)
20.75
Total Debt To Equity (MRQ)
118.88
LT Debt To Equity (MRQ)
118.57
Return on Investment (TTM)
2.79
Return on Equity (TTM)
2.38

Latest News

Latest News

BRIEF-Mednax Says Postponed Date Of Annual Shareholders Meeting To Late-August

* MEDNAX - POSTPONED DATE OF 2020 ANNUAL SHAREHOLDERS MEETING TO LATE-AUGUST 2020 IN CONNECTION WITH CO'S ONGOING DISCUSSIONS WITH STARBOARD VALUE , LP Source text: (https://bit.ly/2B6UqYU) Further company coverage:

BRIEF-Mednax Reports Significant Progress In Strategic Transformation

* MEDNAX ANNOUNCES SIGNIFICANT PROGRESS IN STRATEGIC TRANSFORMATION

BRIEF-Starboard Value LP Raises Share Stake In Box Inc and Mednax Inc

* STARBOARD VALUE LP RAISES SHARE STAKE IN BOX INC BY 60.5% TO 11.67 MILLION CLASS A SHARES - SEC FILING

BRIEF-Mednax Reports Q1 Adjusted Earnings Per Share $0.32

* Q1 ADJUSTED EARNINGS PER SHARE $0.32 FROM CONTINUING OPERATIONS

BRIEF-Mednax Inc - Entered Into A Securities Purchase Agreement To Acquire American Anesthesiology, Inc

* MEDNAX INC - ENTERED INTO A SECURITIES PURCHASE AGREEMENT TO ACQUIRE AMERICAN ANESTHESIOLOGY, INC

BRIEF-MEDNAX Executives Take Temporary Reductions In Cash Compensation

* BOARD, NAMED EXECUTIVE OFFICERS, OTHER MEMBERS OF SENIOR LEADERSHIP AGREED TO VARIOUS TEMPORARY REDUCTIONS IN CASH COMPENSATION

BRIEF-Mednax Withdrawing Previously Announced Q1 And Preliminary Full Year Outlook For 2020

* MEDNAX INC - WITHDRAWING ITS PREVIOUSLY ANNOUNCED Q1 AND PRELIMINARY FULL YEAR OUTLOOK FOR 2020

Starboard picks stake in Mednax, calls for co's sale: WSJ

Activist investor Starboard Value LP is pushing healthcare service provider Mednax Inc to sell all or part of itself, reported the Wall Street Journal citing people familiar with the matter.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up